NCT05909059View on ClinicalTrials.gov

CAR T-cell Therapy in Patients With Renal Dysfunction

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Non-hodgkin Lymphoma,B CellMultiple MyelomaAcute Lymphoblastic Leukemia, Adult
Interventions
DRUG

Fludarabine

Received IV on Days -5 to -3 before CAR T cell therapy

DRUG

Cyclophosphamide

Received IV on Days -5 to -3 before CAR T cell therapy

Trial Locations (1)

30342

RECRUITING

Caitlin Guzowski, Atlanta

All Listed Sponsors
collaborator

Blood and Marrow Transplant Group of Georgia

OTHER

lead

Northside Hospital, Inc.

OTHER